Bench to Bedside: Transforming the Diagnosis and Treatment of CLL

This program consists of 2 modules:



Provided by Imedex®, LLC.

This activity is supported by educational grants from Pharmacyclics, an AbbVie Company and Janssen Biotech, Inc. and TG Therapeutics.

Topic: Hematology/Oncology, Oncology

Target Audience: This educational activity is designed for US-based hematologists, medical oncologists, hematopathologists, other healthcare professionals interested in the therapeutic management of hematologic malignancies.